In re Biolase Technology, Inc. Securities Litigation, No. 8:04-CV-947 (C.D. Cal. July 25, 2006)
N/AOUTCOME: $2.95 million settlement
Defeated motion to dismiss claims alleging violations of § 11 of the Securities Act of 1933.
Newtown, PA
Securities and investment fraud Lawyer at Newtown, PA
Practice Areas: Securities & Investment Fraud, Class Action ... +2 more
OUTCOME: $2.95 million settlement
Defeated motion to dismiss claims alleging violations of § 11 of the Securities Act of 1933.